T1 Energy Inc. (TE): what the price assumes
In the published model solve dated 2026-Q2, anchored at $5.47, T1 Energy Inc. (TE) is priced for today's economics sustained for ~22.1 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-11.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/TE
Headline
| Field | Value |
|---|---|
| Ticker | TE |
| Company | T1 Energy Inc. |
| Sector / Industry | Technology |
| Current price | $5.48/sh |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | revenue-multiple |
| EV / sales paid | 3.5x |
| Steady-state operating margin assumed | 2.9% |
| Must persist for | 22.1y |
Solve inputs: computed at a 11.4% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.9 years.
Reconcile: at the x-ray's 9.3% required return this reads ~16.3 years; the models below use their own rates.
How unusual the bet is: elevated (limited comparison data)
| Reference | Value |
|---|---|
| sustained it ~10 years at this level | 15% |
| implied end-window share | 0% |
Valuation X-Ray
The price is justified by relative-multiple and growth-DCF; asset-based land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 6.82x | 2 | expensive |
| Earnings | — | 0 | — |
| Relative | 0.35x | 2 | justifies |
| Growth | 0.50x | 3 | justifies |
Families that justify the price: Relative, Growth Families that call it expensive: Asset
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.8%); the inversion above states its own rate.
Per-Model Detail (n=7)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $10.88 | 0.50x | yes | Reference only (OCF-based, capex excluded): OCF $0.1B |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | $15.75 | 0.35x | yes | P/S fallback (negative EPS): Sector P/S 5.0x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $0.85 | 6.44x | yes | Book value floor: BV/sh $0.85, ROE negative |
| Two-Stage Excess Return | Asset | $0.76 | 7.20x | yes | Book value with convergence: BV/sh $0.85, ROE converges to ke |
| Discounted Future Market Cap | Growth | $7.94 | 0.69x | yes | Rev $0.9B, growth 30% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.7x / 2.1x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | $26.67 | 0.21x | yes | Margin ramp: -42% → 25% over 7yr, rev growth 30% (input: historical growth; tapered) |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $15.75 | 0.35x | yes | Revenue $0.88B × sector P/S 5.0x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Economic-Unit Decomposition (Sum Of The Parts)
Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.
| Unit | Role | Valuation basis | Revenue | Reported profit | Value evidence | Status |
|---|---|---|---|---|---|---|
| PV Solar Modules (whole-company) | operating | enterprise | 0.8B reported-currency | — | withheld | unresolved no unit value |
No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.
Solvency
| Field | Value |
|---|---|
| Net debt | $332.0m |
| Share count CAGR (dilution) | 26.9% |
| Burning cash | no |
Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.
Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.
Bullet Takeaways
- T1 Energy builds utility-scale solar modules at a 5 GW plant in Dallas and describes itself in its 10-K as "one of the leading solar manufacturing companies in the United States, primarily selling into the utility-scale market, the largest solar market segment in the U.S.", with a second act, domestic cell production in Austin, targeted to start late 2026.
- The risk profile is concentrated in every sense: the FY2025 10-K discloses that "one customer accounted for 78% of our total net sales", the balance sheet carries $332 million of net debt against roughly $46 million of liquid assets, and the share count has grown about 27 percent a year over the past three years.
- The next checkpoint is first cell production at the G2 Austin facility in the fourth quarter of 2026; management targets $375 to $450 million of adjusted EBITDA in 2027 once the plant ramps.
Bull Case
The reasons to walk away from T1 Energy are sitting in plain view. The company loses money at the operating line, with a trailing operating margin around negative 27 percent. One buyer took 78 percent of last year's sales. The share count has compounded upward at roughly 27 percent a year, which means every existing holder's claim on the eventual prize keeps shrinking. Those are the fears. The question is whether the recent data supports them or is starting to undermine them, and the trajectory says the latter.
Start with the top line. First-quarter sales came in at $177.7 million against $53.5 million a year earlier, and the quarter produced $3.9 million of net income from continuing operations alongside the company's first meaningful positive adjusted EBITDA, at $9.1 million. A module plant that was barely shipping a year ago is now running at a revenue pace near $700 million annualized, and the losses that dominate the trailing twelve months are increasingly a picture of the past four quarters rather than the next four. The demand side is doing most of the work: the 10-K points to "robust customer demand for high domestic content solar equipment" and a U.S. market with "more than 45 GWdc forecast through 2030" across utility-scale and commercial segments. T1 is one of a small set of manufacturers positioned to sell American-made modules into that pipeline.
The structural piece of the bull case is vertical integration. Today T1 assembles modules in Dallas from imported cells; the G2 Austin facility is designed to make the cells themselves, which captures more of the federal 45X production credit per watt and hardens the domestic-content claim that customers are paying for. Concrete work began in April, structural steel followed in May, and management still targets first production in the fourth quarter of 2026, with the phase-one financing requirement of roughly $225 million already addressed by a convertible notes offering at a 4.00 percent coupon that raised about $175 million net. The June acquisition of Kore Power for $32 million adds battery capability on top. None of this removes the concentration or dilution problems. It does mean the company that reports 2027 results will look structurally different from the one that produced the trailing numbers, and the market is being asked to price the former.
Bear Case
Today's price is not paying for the module plant in Dallas. It is paying for a specific sequence of future events: the Austin cell facility starts producing on schedule in late 2026, the ramp reaches the $375 to $450 million of adjusted EBITDA management has sketched for 2027, federal 45X credits keep flowing at current rates, and module prices hold while all of that happens. Each link is plausible. The bet requires all of them, and the most fragile link is the one the company controls least. The 10-K flags that "Any changes to the statutes or regulatory guidance regarding Section 45X of the IRC" could move the economics, and a manufacturing story whose margin structure leans on a tax credit is exposed to a pen stroke in Washington in a way no operational excellence can hedge.
The competitive backdrop compounds the fragility. T1's own filing describes competitors, many in China, that may sell "below their manufacturing costs, in order to generate sales, and may do so for a sustained period", with "direct or indirect access to sovereign capital or other forms of state support", and warns that "excess capacity will continue to put pressure on pricing". Tariff walls and domestic-content rules are the counterweight, but those are policy artifacts too, which routes the bear case back to the same dependency: the moat here is substantially legislative. Meanwhile the revenue base rests on a single relationship. The FY2025 10-K discloses one customer at 78 percent of total net sales, so a renegotiation, a delayed project pipeline, or a lost contract does not dent the story, it removes most of it.
The balance sheet leaves little room for the schedule to slip. Net debt stands at $332 million, liquid assets at roughly $46 million, and operating profit is still negative, so conventional coverage math does not yet apply to this company. Funding has come from the equity and convertible markets, and the share count has grown about 27 percent a year for three years, a pace that transfers value from existing holders every time the company needs capital. At about 4.3 times revenue, the price already embeds the business growing at the fastest pace it can fund internally for roughly 25 years; of comparable fast-growers, only about 15 percent have sustained that kind of pace for even a decade. If the Austin ramp lands late or lean, the next capital raise happens from a weaker position, and the dilution machine that funded the buildout keeps running against the holders who financed it.
Valuation
At $6.86, the market is paying about 4.3 times revenue for a business that currently runs a negative 27 percent operating margin. Worked backward, that price implies T1 eventually earns an operating margin of roughly 2.9 percent while growing revenue at its self-funding ceiling, the fastest pace it can finance without new capital, for something like 25 years. Keep those figures approximate; they describe the shape of the bet rather than a measurement. The striking part is not the margin, which is thin even by manufacturing standards, but the duration: of comparable fast-growing companies, only about 15 percent sustained that pace for even ten years.
The methods disagree along a clean fault line. The asset-value lens is brutal: book value sits near $0.83 per share, so the price stands at close to nine times what balance-sheet-based approaches support. No earnings-power method applies at all, because there are no positive earnings to capitalize. What reaches the price is the forward-looking side: a sales-multiple comparison against the sector lands well above today's level, and the growth projections get there only by assuming revenue compounds around 30 percent with losses swinging to strongly positive margins over roughly seven years, with the terminal multiple held flat at today's level. The pattern is the signal. Everything that anchors on what the company has already demonstrated finds the stock expensive; everything that anchors on what the ramp could produce finds it cheap. The price sits entirely on the ramp.
Two filing-sourced facts bound the range of outcomes. On the revenue input, one customer accounted for 78 percent of FY2025 net sales, so the top line the multiples rest on is closer to a single contract than a diversified book. On the margin input, the 10-K itself warns of "substantial downward pressure on the prices of solar cells and modules" from industry overcapacity, which is direct pressure on the thin terminal margin the price requires. The balance sheet frames the downside: $332 million of net debt against about $46 million of liquid assets, debt language in the filing acknowledging terms that "make it more difficult to satisfy our financial obligations, including payments on our indebtedness", and a share count rising about 27 percent a year as the buildout is financed. The Austin plant is the whole valuation question; the balance sheet is the clock it runs against.
Catalysts
The first quarter, reported May 12, 2026, marked the inflection the story needs: sales of $177.7 million versus $53.5 million a year earlier, net income from continuing operations of $3.9 million, and record adjusted EBITDA of $9.1 million, though the bottom line still showed a $21.4 million net loss attributable to common stockholders, about $0.08 per share, driven by discontinued operations. Management framed 2026 as a bridge year, with the real earnings power arriving in 2027 at a targeted $375 to $450 million of adjusted EBITDA once cell production scales.
The G2 Austin facility is the calendar that matters. Concrete works commenced in April 2026, first structural steel went up in May, and the company continues to target initial cell production in the fourth quarter of 2026. Financing for the roughly $225 million phase-one requirement was substantially addressed by a 4.00 percent convertible notes offering completed in the first quarter. On June 30, 2026 the company added a $32 million acquisition of Kore Power, funded with a mix of equity, cash, and assumed debt, extending the platform into battery storage.
The watch items from here are sequential: the second-quarter print for evidence the module business held its first-quarter pace, construction milestones at Austin through the summer and fall, and any Washington movement on Section 45X guidance, which sets the credit economics the 2027 targets lean on. Analysts have recently trimmed price targets on softer revenue growth and margin assumptions, so the burden of proof sits on execution rather than sentiment.
Peer Cohorts (Per Segment, With Filing Citations)
PV Solar Modules (whole-company) (reported)
- FSLR (First Solar Inc)
- FY2025 10-K: …and financing these projects, typically supported by contracted revenues with creditworthy counterparties. Additionally, the unprecedented expansion of data centers, AI workloads, electrification of industrial processes, and broader economic growth has increased demand for new generation capacity and has expanded the…
- FY2025 10-K: …in the Chinese solar supply chain have emerged in recent years, which means we also compete on our approach to responsible sourcing and supply chain due diligence. Our differentiated technology, integrated manufacturing process, and tightly controlled supply chain help limit the risks associated with outsourcing and…
- NXT (Nextracker Inc)
- FY2025 10-K: …backlog as executed EPC or VCA contracts or purchase orders with deposits of cash paid or financial equivalents, identified named project sites, product and volume requirements, and ship dates. Sales and marketing Our sales and marketing strategy is focused on building long-term relationships with key parties…
- FY2025 10-K: …is the sale of solar tracking products. Our customers include EPCs, as well as solar project developers and owners. We usually enter into a different contract with our customers for each individual solar project. Contracts typically stipulate total price, technical solution, specifications of the system sold,…
- SEDG (SolarEdge Technologies Inc)
- FY2025 10-K: …the course of employment with us. Our customers and business partners are required to enter into confidentiality agreements before we disclose any sensitive aspects of our technology or business plans. Competition The markets for our smart energy and PV products are competitive, and we compete with providers of smart…
- FY2025 10-K: …prices more than anticipated, or if we are unable to offset any future reductions in our average selling prices by increasing our sales volume, reducing our costs and expenses or introducing new products, our revenues and gross profit would suffer. In addition, competitors may be able to develop new technologies or…
- ENPH (Enphase Energy Inc)
- FY2025 10-K: …lifecycle. Our on-demand service platform matches cleantech asset owners with a local network of independent professionals for installation, maintenance and repair services. In addition, our Enphase Appointments Program provides qualified solar appointments to installers to help increase volumes and improve customer…
- FY2025 10-K: …per kilowatt hour ("kWh") to make solar-plus-storage resilient, sustainable and affordable for the masses. • Focus on the homeowner, distributor and installer partners. We are focused on making it easier for our distributors, installers and customers to do business and generating revenue through digitalization of the…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Economic-unit decomposition (SOTP): each disclosed business unit is assigned its native valuation basis before any multiple is applied. Operating units are valued on enterprise value; funded financial units are valued on their own common equity, because their borrowings fund earning assets rather than levering the parent. A company total is stated only once every material unit carries a supported value and the parent capital bridge reconciles.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Q1 2026 earnings release and call, May 12, 2026 · Q1 2026 earnings release, May 12, 2026 · company announcement, June 30, 2026 · Q1 2026 earnings call, May 12, 2026 · Simply Wall St, June 2026